Objective To validate the A merican T hyroid A ssociation ( ATA ) initial risk of recurrence
scheme and the M emorial S loan K ettering C ancer C enter ( MSKCC ) response to therapy re‐…

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total thyroidectomy (TT…

Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Thyroid cancer in children and adolescents is usually a major concern for physicians, patients,
and parents. Controversies regarding the aggressiveness of the clinical presentation and …

Background and Objective. An individualized risk-based approach to the treatment of thyroid
cancer is being extensively discussed in the recent literature. However, controversies about …

Background: The incidence of pediatric differentiated thyroid carcinoma (DTC) has been
rising in recent years, and the main risk factors for recurrence are lymph node and distant …

Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease
caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (…

Purpose To evaluate the predictive capacity of clinical and laboratory variables in relation to
the success of ablation. The variables studied were as follows: thyroglobulin (Tg) in …

Background Medullary thyroid cancer (MTC) is a rare but potentially life-threatening disease
with limited therapeutic options. As a neuroendocrine tumor, MTC expresses somatostatin …